Skip to content
Screener

Total Assets at other companies

Avalo Therapeutics logo
Avalo TherapeuticsAVTX
$490.78M+288%
Cullinan Therapeutics, Inc. logo
Cullinan Therapeutics, Inc.CGEM
$363.79M-30.1%
Aquestive Therapeutics, Inc. logo
Aquestive Therapeutics, Inc.AQST
$141.13M+38.0%
Celldex Therapeutics logo
Celldex TherapeuticsCLDX
$782.35M+13.0%
Alumis Inc. logo
Alumis Inc.ALMS
$671.59M+157%
Nektar Therapeutics logo
Nektar TherapeuticsNKTR
$763.27M+198%

Other financials

Income statement

See full
Revenue$700.0K-53.3%
Operating income-$50.6M-23.1%
Net income-$50.4M-20.3%
EPS (diluted)-$0.12+61.3%

Balance sheet

See full
Cash & equivalents$174.9M+69.5%
Total debt$7.7M+0.1%
Total equity$160.4M+86.1%

Cash flow

See full
Operating cash flow-$52.6M-55.2%
CapEx$400.0K
Free cash flow-$53.0M-56.3%

Valuation

See full
Market cap$847.16M+218%
Enterprise value$679.96M+297%
P/S168.8×+100×

Profitability

See full
Operating margin-3,543.1%+523pp
Net margin-3,506.5%+442pp
FCF margin-3,399.3%+3,268pp

Returns & leverage

See full
Return on equity-142.7%-5.0pp
Debt / equity0.0×
Current ratio3.7×+1.3×

Where this comes from

Reported directly by DBV Technologies in its filing.

Tagged under the XBRL concept us-gaap:Assets.

The source filing: DBV Technologies’s 10-Q, filed July 16, 2026.

Filed
Jul 16, 2026, 4:08 PM EDT
Fiscal quarter
Q2 FY2026
Calendar quarter
Q2 2026
Accession
0001628280-26-048453
Line itemNoteJune 30, 2026December 31, 2025
Right-of-use assets65.94.6
Other non-current assets55.85.8
Total non-current assets21.320.8
Total Assets223.2233.7
Liabilities and shareholders' equity
Current liabilities:
Trade payables739.440.9
Short-term operating leases' liabilities60.81.1

Item 1C. Condensed Consolidated Statements of Financial Position (Unaudited) as of

FAQ

What is DBV Technologies's total assets?
DBV Technologies (DBVT) reported total assets of $223.2M in Q2 2026.
How has DBV Technologies's total assets changed year-over-year?
DBV Technologies's total assets increased by 55.6% year-over-year, from $143.43M to $223.2M.
What is the long-term trend for DBV Technologies's total assets?
Over 5 years (2020 to 2025), DBV Technologies's total assets has grown at a -3.0% compound annual growth rate (CAGR), from $272.25M to $233.7M.
What does total assets mean?
The sum of everything the company owns — current assets, property, investments, goodwill, intangibles, and all other assets.

Ask your AI about DBV Technologies's total assets.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI
Harbor at dusk
Claude